The new observation, made by UNC School of Medicine’s Stephan Moll, MD, and Jacquelyn Baskin-Miller, MD, suggests that a life-threatening blood clotting disorder can be caused by an infection with adenovirus, one of the most common respiratory viruses in pediatric and adult patients.
Experts at the Institute for Nicotine and Tobacco Studies at Rutgers served as guest editors of “Regulatory Research Advances on Premium Cigars,” a special supplement of Nicotine & Tobacco Research sponsored by the Center for Coordination of Analytics, Science, Enhancement, and Logistics in Tobacco Regulatory Science with funding from the National Institute on Drug Abuse at the National Institutes of Health and the Food and Drug Administration’s Center for Tobacco Products.
The impact of particulate matter air pollution on death and disability is on the rise worldwide, according to new research published today in the Journal of the American Heart Association.
Researchers from University of British Columbia and Michigan State University have invented a system that can quickly and inexpensively detect airborne viruses using the same technology that enables high-speed trains.
The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) collaboration announced today the start of a phase 2b/c clinical trial, sponsored by the Bill & Melinda Gates Medical Research Institute (Gates MRI).
Not for public release
This news release is embargoed until 7-Aug-2023 5:00 PM EDT
Released to reporters: 1-Aug-2023 2:00 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 7-Aug-2023 5:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
Critically ill children on ventilator support can experience a mismatch between their
breathing efforts and) the rhythm delivered by the ventilator. This mismatch, called patient-ventilator asynchrony (PVA), is difficult to detect and can worsen patient outcomes.
In a study publishing Aug. 1, 2023, in the Journal of the American Medical Association (JAMA), the research team found that half of the participants with extensive tobacco exposure have a high level of ongoing respiratory symptoms, including shortness of breath, daily cough and phlegm, and decreased ability to exercise, but perform well in the breathing tests used to diagnose COPD.
The inaugural cohort of President Biden’s Cancer Moonshot Scholars, announced in a White House press release last Thursday, includes University of Kentucky Markey Cancer Center researcher Laurie McLouth, Ph.D.McLouth is one of 11 emerging leaders in cancer research and innovation selected as a scholar, the White House announced Aug. 3.
Huntsman Cancer Institute investigators find a way to reduce infection after pancreatic surgery, discover the best treatment combination that’s cost effective for prostate cancer patients, and learn lung cancer patients receiving chemotherapy have more emergency department visits. They also found a genetic mutation that makes anemia more likely after chemotherapy, and a non-invasive way to remove brain tumors.
Targeted therapies have revolutionized cancer treatment and the field of oncology. The FDA has approved over 70 targeted therapies for various cancer types, including lung cancer. Epidermal growth factor receptor (EGFR) mutations are found in a significant proportion of lung adenocarcinomas, and the use of tyrosine kinase inhibitors (TKIs) such as osimertinib, have improved patient outcomes.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Recent developments include a novel biomarker that may predict the aggressiveness of pancreatic cancer precursors, insights into the structure and function of a breast and ovarian cancer susceptibility gene, a new approach to overcoming treatment resistance in ovarian cancer, distinguishing features of young-onset rectal cancer, a biomarker and potential target for metastatic lung cancer, machine learning models to better predict outcomes of patients with mantle cell lymphoma (MCL), and a promising therapy for patients with relapsed/refractory MCL.
Based on decades of work to uncover the underlying mechanisms of asthma and other respiratory conditions, researchers at McMaster University and St. Joseph’s Healthcare Hamilton have produced a simple, rapid test that can identify the presence of a key driver of severe asthma.
Ochsner Medical Center - New Orleans (OMC), inclusive of Ochsner Medical Center- West Bank and Ochsner Baptist, has been named by U.S. News & World Report to its 2023-2024 Best Hospitals. Additionally, OMC is the #1 hospital in the New Orleans metro area.
On World Lung Cancer Day, Aug. 1, the Forum of International Respiratory Societies (FIRS) and its founding member, the American Thoracic Society, stress the importance of understanding lung cancer risk factors, as well as the importance of early detection through screening, and treatment.
Newborn screening for cystic fibrosis (CF) was fully implemented in all 50 states in the U.S. by 2010, but delays in timeliness of evaluation for infants with positive newborn screen tests persist. Through evaluation of national patient registry data, Dr. Martiniano and her team determined that later initiation of CF care is associated with poorer long-term nutritional outcomes.
The planet experienced the hottest day on record earlier this month and climate projections estimate the intensity of heat waves and poor air quality will increase and continue to cause severe impacts. Researchers from the University of Waterloo and Toronto Metropolitan University have refined and expanded a method of data collection to assess their health impacts.
The ultra-soft tentacle, which measures just 2 millimetres in diameter and is controlled by magnets, can reach some of the smallest bronchial tubes and could transform the treatment of lung cancer.
Not for public release
This news release is embargoed until 26-Jul-2023 5:00 PM EDT
Released to reporters: 26-Jul-2023 3:05 PM EDT
A reporter's PressPass is required to
access this story until the embargo expires on 26-Jul-2023 5:00 PM EDT
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
In a new study, scientists at La Jolla Institute for Immunology (LJI) compared the immune response of individuals who received older versus newer versions of the whooping cough vaccine. The unexpected findings may help explain the recent rise in whooping cough cases and point to potential targets for the next generation of vaccines.
PBD Biotech developers of Actiphage TB, a ground-breaking phage-based diagnostic for laboratory tuberculosis testing, has today announced it has secured the grant of a US patent for its diagnostic kit. The company is exhibiting in the AACC Clinical Lab Expo on booth #4578.
Today, at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo, scientists will present new data about rates of co-infections with SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) in the United States.
Omega-3 fatty acids, which are abundant in fish and fish oil supplements, appear promising for maintaining lung health, according to new evidence from a large, multi-faceted study in healthy adults supported by the National Institutes of Health.
Omega-3 fatty acids, which are abundant in fish and fish oil supplements, appear promising for maintaining lung health, according to a Cornell-led study supported by the National Institutes of Health (NIH).
The first study in the world to compare cholesterol-lowering medications on a range of diseases has good and bad news for more than 200 million people.
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Hazy, hazardous conditions from climate change-driven Canadian wildfires have prompted researchers to examine the physicochemical and toxicological properties.
Fiscal year 2023, which ended June 30, proved to be the busiest year yet for Cedars-Sinai’s Comprehensive Transplant Center and Smidt Heart Institute, with more than 600 organs transplanted.
Research increasingly reveals health risks of e-cigarette use, and more studies are needed about the long-term impact e-cigarettes may have on the heart and lungs.
As a result of the COVID-19 pandemic, respiratory syncytial virus (RSV) surges in young children occurred outside the usual November to March season, when immune-based prophylactic is available to protect children at high risk for severe illness.
While pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this therapy. Treatment failure, researchers say, is often caused by differences in the tumor microenvironment.
The Tobacco Prevention and Evaluation program (TPEP) in the UNC School of Medicine has been awarded a two-year, $887,431 contract from JUUL Settlement funds received by the NC Department of Health and Human Services to better understand electronic cigarette use among our youth and young adults.
The American Association for Thoracic Surgery (AATS) and Memorial Sloan Kettering Cancer Center’s (MSK) Thoracic Surgery Oncology Group (TSOG) completed its first clinical trial involving 330 patients who have ground glass lung nodules identified on a CT scan.
Now that the emergency phase of the COVID-19 pandemic has ended, scientists are looking at ways to surveil indoor environments in real time for viruses. By combining recent advances in aerosol sampling technology and an ultrasensitive biosensing technique, researchers at Washington University in St. Louis have created a real-time monitor that can detect any of the SARS-CoV-2 virus variants in a room in about 5 minutes.
Below are summaries of recent Fred Hutchinson Cancer Center research findings and other news. If you’re looking for resources who can comment on skin cancer awareness and skin protection during the summer months, see our list of experts and reach out to [email protected] to set up interviews.
Mickey Rogers, a Linus Pauling Distinguished Postdoctoral Fellow at the Environmental Molecular Sciences Laboratory (EMSL) talks about her research on how algae particles in the atmosphere affect climate and human health.
In 2019, incarcerated people across the globe developed tuberculosis (TB) at nearly 10 times the rate of people in the general population, according to a new study led by Boston University School of Public Health (BUSPH).
In support of the second annual World Bronchiectasis Day, July 1, the Forum of International Respiratory Societies, of which the American Thoracic Society is a founding member, is joining the COPD Foundation and several global organizations to raise global awareness, share knowledge, and discuss ways to reduce the burden of bronchiectasis for patients and their families worldwide.
The Radiological Society of North America (RSNA) announced today that its leading medical imaging research journal, Radiology, maintains the largest impact factor in its category. In addition, RSNA’s subspecialty journals, Radiology: Artificial Intelligence, Radiology: Cardiothoracic Imaging and Radiology: Imaging Cancer have achieved impact factors for the first time, and RadioGraphics continues to excel, according to the newly released 2023 update to the Clarivate Analytics Journal Citation Reports.
A blood-based four-protein panel (4MP), when combined with a lung cancer risk model (PLCOm2012), can better identify those at high risk of dying from lung cancer than the current U.S. Preventive Services Task Force (USPSTF) criteria.